You have 9 free searches left this month | to do more
Showing 1 - 25 of
88 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Active, not recruiting
  • Triple Negative Metastatic Breast Cancer
  • +3 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • +3 more
  • Brussels, Belgium
  • +2 more
2022-03-02
Mar 2, 2022
A
Active, not recruiting
  • Ovarian Neoplasms
  • +2 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • Brussels, Belgium
  • +4 more
2021-11-22
Nov 22, 2021
A
Active, not recruiting
  • Breast Neoplasms
  • KU-0059436 (AZD2281) (PARP inhibitor)
  • Duarte, California
  • +24 more
2022-03-11
Mar 11, 2022
C
Not yet recruiting
  • Pancreatic Cancer
  • (no location specified)
2021-10-21
Oct 21, 2021
U
Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-04-04
Apr 4, 2022
T
Completed
  • Locally Advanced Malignant Neoplasm
  • +2 more
  • Amsterdam, Netherlands
    The Netherlands Cancer Institute
2021-08-03
Aug 3, 2021
T
Recruiting
  • Breast Cancer Metastatic
  • Breast Cancer
  • Houston, Texas
    Houston Methodist Cancer Center
2021-07-16
Jul 16, 2021
M
Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-01
Mar 1, 2022
C
Recruiting
  • Renal Cell Cancer
  • Cambridge, England, United Kingdom
    Addenbrooke's Hospital
2021-05-21
May 21, 2021
T
Completed
  • Ovarian Cancer
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
2022-02-04
Feb 4, 2022
T
Active, not recruiting
  • Laryngeal Cancer Stage II
  • +3 more
  • Amsterdam, Netherlands
    The Netherlands Cancer Institute
2021-08-03
Aug 3, 2021
S
Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
2022-03-14
Mar 14, 2022
T
Active, not recruiting
  • Metastatic Malignant Neoplasm in the Chest Wall
  • Recurrent Breast Carcinoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
2021-10-18
Oct 18, 2021
M
Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
2022-03-09
Mar 9, 2022
N
Recruiting
  • Endometrial Serous Adenocarcinoma
  • +2 more
  • Phoenix, Arizona
  • +3 more
2022-01-04
Jan 4, 2022
U
Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Laboratory Biomarker Analysis
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-04-27
Apr 27, 2021
O
Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
2022-02-17
Feb 17, 2022
U
Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Durvalumab
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-21
Dec 21, 2021
R
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +10 more
  • San Francisco, California
    University of California, San Francisco
2021-04-05
Apr 5, 2021
U
Terminated
  • Prostate Adenocarcinoma Without Neuroendocrine Differentiation
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2020-09-01
Sep 1, 2020
M
Recruiting
  • Advanced Breast Carcinoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-31
Mar 31, 2022
N
Suspended
  • Recurrent Ovarian High Grade Serous Adenocarcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
  • Phoenix, Arizona
  • +8 more
2022-04-05
Apr 5, 2022
O
Completed
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
2020-11-18
Nov 18, 2020
O
Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +11 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
2022-03-22
Mar 22, 2022